Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00951743
Recruitment Status : Unknown
Verified August 2009 by Rapid Laboratories Inc..
Recruitment status was:  Recruiting
First Posted : August 4, 2009
Last Update Posted : August 11, 2009
Sponsor:
Information provided by:
Rapid Laboratories Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2010
  Estimated Study Completion Date : July 2010